Projects

Mgr. Timea Kurdiová, PhD.
researcher

International

Current
  • Alzheimer\'s Disease Diagnostics Innovation and Translation to Clinical Practice in Central Europe
    Program: Horizon Europe
    Duration: 1. 1. 2023 – 31. 12. 2026
Finished
  • Myokines and metabolically active molecules in the pathogenesis of idiopathic inflammatory myopathies
    Program: Other
    Duration: 1. 5. 2021 – 31. 12. 2024
  • Novel strategies aimed to improve the physical fitness, clinical symptoms and quality of life in the early-stage Parkinson’s disease patients: Regular exercise training and carnosine
    Program: Bilateral - other
    Duration: 1. 1. 2019 – 31. 12. 2021
  • Skeletal muscle metabolic abnormalities in patients with idiopathic inflammatory myopathies
    Program: Bilateral - other
    Duration: 1. 1. 2016 – 31. 12. 2019
  • Skeletal muscle as a mediator of beneficial effects of regular exercise on cognitive functions and metabolism in patients with Alzheimer\'s disease: the role of muscle myokines and microRNAs.
    Program: Bilateral - other
    Duration: 1. 1. 2014 – 31. 12. 2016
  • Metabolic health and muscle secretory profile in aerobic and resistance trained obese pre-diabetic individuals
    Program: Multilateral - other
    Duration: 15. 2. 2010 – 14. 2. 2013
  • Adipose tissue and skeletal muscle plasticity in metabolic health and in insulin resistance
    Program: Multilateral - other
    Duration: 25. 1. 2010 – 24. 1. 2013
  • Lipid droplets as dynamic organelles of fat deposition and release: translational research towards human disease
    Program: FP7
    Duration: 1. 5. 2008 – 31. 10. 2012

National

Current
  • Molecular mediators of the response to complex lifestyle intervention in patients with obesity: Regulation of metabolic flexibility in vitro and in vivo
    Program: SRDA
    Duration: 1. 7. 2024 – 30. 6. 2028
  • Extracellular vesicles a tool integrating adaptive response to exercise: in vitro and in vivo studies
    Program: VEGA
    Duration: 1. 1. 2024 – 31. 12. 2027
  • The potential of physical activity to influence the proliferative capacity and characteristics of tumor cells: identification of exerkines and mechanisms with antitumor effects
    Program: VEGA
    Duration: 1. 1. 2023 – 31. 12. 2026
  • Mitochondrial disease in heart failure
    Program: SRDA
    Duration: 1. 7. 2022 – 30. 6. 2026
  • Effects of regular exercise training on molecular, cellular and whole body processes associated with ageing: : Multi-organ integrative approach
    Program: VEGA
    Duration: 1. 1. 2022 – 31. 12. 2025
Finished
  • Identification and validation of biomarkers and underlying molecular pathways of late toxicity of curative treatment in testicular germ cell tumors
    Program: SRDA
    Duration: 1. 7. 2020 – 30. 6. 2024
  • Exercise in prevention & treatment of chemotherapy-related late toxicity in testicular germ cell cancer survivors: the role of skeletal muscle
    Program: VEGA
    Duration: 1. 1. 2020 – 31. 12. 2023
  • Mechanisms of skeletal muscle adaptation to regular exercise in patients with chronic metabolic and inflammatory disease
    Program: VEGA
    Duration: 1. 1. 2019 – 31. 12. 2022
  • Molecular mediators of physical exercise and carnosine induced effects in patients with preclinical and early stage neurodegenerative disease
    Program: SRDA
    Duration: 1. 7. 2016 – 31. 12. 2020
  • Multiple sclerosis - The role of mitochondrial dysfunction in insulin resistance.
    Program: SRDA
    Duration: 1. 7. 2016 – 31. 12. 2020
  • Transfer of genetic knowledge of endocrine research into clinical praxis
    Program: EU Structural Funds Research & Development
    Duration: 1. 11. 2010 – 31. 8. 2013
Employees